NRX Pharmaceuticals (NRXP)

• Market cap: $74.7M
• 1 day: -1.77%
• 5 days: 0%
• 1 month: 22.65%
• 3 months: 0%
• 6 months: -29.97%
• Year to date: -15.27%
• 1 year: 24.02%
• 5 years: -99.37%
• 10 years: -97.69%
• Sector: Healthcare
• Industry: Biotechnology

About: NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Employees: 29